Esafoxolaner/eprinomectin/praziquantel explained

Type:combo
Component1:Esafoxolaner
Class1:aryl isoxazoline
Component2:Eprinomectin
Class2:avermectin anthelmintic
Component3:Praziquantel
Class3:pyrazinoisoquinoline anthelmintic
Tradename:Nexgard Combo
Dailymedid:Esafoxolaner, eprinomectin, and praziquantel
Routes Of Administration:Topical
Atc Supplemental:,
Legal Ca:Rx-only
Legal Ca Comment:[1] [2]
Legal Us:Rx-only
Legal Us Comment:[3]

Esafoxolaner/eprinomectin/praziquantel, sold under the brand name Nexgard Combo, is a fixed-dose combination medication used for the treatment and control of flea infestations, ticks, ear mites, and infections caused by tapeworms and Toxocara cati in cats.[4] It is also used for the prevention of heartworm disease Dirofilaria immitis. It contains esafoxolaner, an aryl isoxazoline; eprinomectin, an avermectin anthelmintic; and praziquantel, a pyrazinoisoquinoline anthelmintic.

Veterinary uses

In the United States, esafoxolaner/eprinomectin/praziquantel is indicated for the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of roundworm (fourth stage larval and adult Toxocara cati), hookworm (fourth stage larval and adult Ancylostoma tubaeforme; adult Ancylostoma braziliense), and tapeworm (Dipylidium caninum) infections. It kills adult fleas (Ctenocephalides felis) and is indicated for the treatment and prevention of flea infestations and the treatment and control of Ixodes scapularis (black-legged tick) and Amblyomma americanum (lone star tick) infestations for one month in cats and kittens eight weeks of age and older, and weighing 1.8lb or greater.[5] [6]

Notes and References

  1. Web site: Nexgard Combo Product information . . 5 January 2022 . 14 April 2024.
  2. Web site: Health product highlights 2021: Annexes of products approved in 2021 . . 3 August 2022 . 25 March 2024.
  3. Web site: Nexgard Combo- esafoxolaner, eprinomectin, and praziquantel solution . DailyMed . 7 March 2024 . 14 April 2024.
  4. Beugnet F . NexGard® Combo (esafoxolaner, eprinomectin, praziquantel), a new endectoparasiticide spot-on formulation for cats . Parasite . Paris, France . 28 . E1 . 2021 . 33812448 . 8019561 . 10.1051/parasite/2021013 .
  5. Web site: Nexgard Combo 141-570 . U.S. Food and Drug Administration . 14 April 2024.
  6. Web site: Nexgard Combo (esafoxolaner, eprinomectin, and praziquantel topical solution) Cats . New Animal Drug Application . U.S. Food and Drug Administration . NADA 141-570 .